Access cutting-edge copd treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access copd specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related copd treatment provided free
This is a randomized, double-blind, placebo-controlled, two-period cross-over study of nebulized ensifentrine (3 mg) or placebo administered BID for two 8-week Treatment Periods. All participants with receive both ensifentrine and placebo during participation. There are 7 in-clinic visits over a total duration of up to 24 weeks participation.
Sponsor: Verona Pharma plc
Check if you qualify for this copd clinical trial in Birmingham, AL
If you're searching for copd treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.